Innovita Biological Technology Co., Ltd. (SHA:688253)

China flag China · Delayed Price · Currency is CNY
53.69
+0.92 (1.74%)
At close: May 12, 2026
Market Cap7.12B +64.0%
Revenue (ttm)323.87M -40.8%
Net Income91.39M -53.4%
EPS0.67 -53.4%
Shares Out134.87M
PE Ratio78.72
Forward PE56.74
Dividend0.56 (1.11%)
Ex-Dividend Daten/a
Volume2,923,693
Average Volume3,248,628
Open52.66
Previous Close52.77
Day's Range52.16 - 55.00
52-Week Range29.99 - 53.77
Beta1.16
RSI75.10
Earnings DateApr 28, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products. It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepatitis test. The company was founded in 2006 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 558
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688253
Full Company Profile

Financial Performance

In 2025, SHA:688253's revenue was 422.03 million, a decrease of -32.08% compared to the previous year's 621.39 million. Earnings were 146.04 million, a decrease of -40.84%.

Financial Statements